Regulations.gov document
Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting; Establishment of a Public…
Notice · FDA-2022-N-1946 · posted Sep 6, 2022
Key facts
| Document ID | FDA-2022-N-1946-0001 |
|---|---|
| Title | Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments |
| Document type | Notice |
| Subtype | Request for Comments |
| Agency | FDA |
| Docket | FDA-2022-N-1946 |
| Posted | Sep 6, 2022 |
| Federal Register citation | 87 FR 54512 |
| FR document number | 2022-19159 |
| Comment period opens | Sep 6, 2022 |
| Comments due | Nov 8, 2022 |
| Effective date | Sep 6, 2022 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: